Why This Landed on My Radar
Patient Square Capital just orchestrated an all-cash acquisition that’ll create the dominant mobility and prosthetics platform in the country - over 1,125 sites serving 1.5 million patients. If you’re wondering where private equity money is flowing in healthcare right now, this deal tells the story: They’re buying up the unsexy, essential services that touch our most vulnerable patients and consolidating market share while we’re all distracted by the latest AI headlines.
Here’s What’s Going On
Hanger, Inc., the orthotic and prosthetic care leader that Patient Square took private back in 2022, just signed a definitive agreement to acquire Numotion, one of the largest providers of Complex Rehabilitation Technology (CRT) and mobility solutions in the country. The combined entity - Hanger Numotion - will be majority-controlled by Patient Square Capital, with Numotion being sold by primary investor AEA Investors and minority backer LLR Partners.
This is an all-cash deal, and the structure matters. Both brands will keep their consumer-facing names and day-to-day clinical operations separate, which means patients and referring providers won’t see immediate disruption. But behind the scenes, they’re combining supply chains, payer contracts, and capital deployment - the classic PE playbook for margin expansion.
Mike Swinford, Numotion’s CEO since 2014 and former President and CEO of GE Healthcare Services, will lead the combined organization. That’s the tell that this isn’t just a tuck-in acquisition - they’re building a platform designed to dominate the mobility space from wheelchairs to prosthetics.
What This Means for Your Practice
Here’s why this matters to those of us running independent primary care practices in Texas: Our diabetic patients with amputations, our stroke survivors needing wheelchairs, our pediatric cerebral palsy patients requiring custom mobility equipment - they’re all going to be channeled through an increasingly consolidated network of providers. And when consolidation happens, the power dynamics shift away from independent physicians.
In Texas, where we have the largest uninsured population in the nation and no Medicaid expansion, our most vulnerable mobility patients are already navigating a nightmare of prior authorizations and coverage denials. Now imagine that landscape with one dominant player controlling both O&P and CRT services. The negotiating leverage shifts entirely to the platform and the payers who contract with them. If you’ve spent time fighting BCBS Texas or United for wheelchair approvals, you know exactly what I’m talking about.
This deal also signals something bigger: PE firms are systematically buying up the ancillary and specialty services that primary care depends on. First it was urgent care and ER staffing, then home health and hospice, now mobility and durable medical equipment. Every time one of these consolidations happens, our referral networks get narrower, our patients face longer wait times, and our ability to coordinate truly patient-centered care gets harder.
For practices with significant Medicare Advantage populations - especially those managing V28 HCC coding and trying to maximize quality metrics - mobility equipment and prosthetic care directly impacts your Frailty indicators, your HEDIS measures, and your ability to keep high-risk patients out of the hospital. When the mobility provider network consolidates, your ability to get timely equipment approvals and coordinate transitions of care becomes someone else’s business decision, not a clinical one.
Key Takeaways
- Private equity is systematically consolidating the ancillary services your patients depend on - from mobility equipment to prosthetics, creating dominant platforms with significant pricing and access leverage
- Your diabetic amputees, stroke survivors, and complex rehab patients will increasingly flow through consolidated networks, potentially creating referral bottlenecks and prior auth delays
- For MA practices managing V28 risk adjustment and quality metrics, mobility equipment delays directly impact Frailty scores, HEDIS measures, and hospital readmission rates
- Texas’s lack of Medicaid expansion makes these consolidations even more challenging - uninsured and underinsured patients have fewer options when competition disappears
- Building direct relationships with remaining independent DME and mobility providers may be a strategic move before this market fully consolidates
What Smart Practices Are Doing
The forward-thinking practices I’m talking to are mapping their referral networks now - identifying which mobility and DME providers are still independent, building direct relationships, and creating backup pathways before the market fully consolidates. Some are also leveraging their EHR systems to track mobility equipment order-to-delivery times and using that data in MA contract negotiations to demonstrate care coordination challenges.
Source
Hanger to Acquire Numotion in Cash Transaction to Create “Hanger Numotion” Under Patient Square Capital - HIT Consultant
Primary Care Perspective delivers curated intelligence from trusted healthcare sources.
© 2026 Primary Care Perspective | Texas Edition